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The intricacies involving the role of interferon-gamma (IFN-γ) in herpesvirus infection and
persistence are complex. Herpes simplex virus type 1 (HSV-1) uses a variety of receptors
to enter cells and is transported to and from the host cell nucleus over the microtubule railroad via retrograde and anterograde transport. IFN-γ exerts dual but conflicting effects on
microtubule organization. IFN-γ stimulates production of suppressors of cytokine signaling
1 and 3 (SOCS1 and SOCS3), which are involved in microtubule stability and are negative
regulators of IFN-γ signaling when overexpressed. IFN-γ also interferes with the correct
assembly of microtubules causing them to undergo severe bundling, contributing to its
anti-viral effect. Factors leading to the decision for a replicative virus lytic cycle or latency
in the trigeminal ganglion (TG) occur on histone 3 (H3), involve IFN-γ produced by natural killer cells and non-cytolytic CD8+T cells, SOCS1, SOCS3, and M2 anti-inflammatory
microglia/macrophages maintained by inhibitory interleukin 10 (IL-10). Both M2 microglia
and CD4+ CD25+ Foxp3+ Treg cells produce IL-10. Histone deacetylases (HDACs) are epigenetic regulators maintaining chromatin in an inactive state necessary for transcription of
IFN-γ-activated genes and their anti-viral effect. Following inhibition of HDACs by stressors
such as ultraviolet light, SOCS1 and SOCS3 are acetylated, and chromatin is relaxed and
available for virus replication. SOCS1 prevents expression of MHC class 1 molecules on
neuronal cells and SOCS3 attenuates cytokine-induced inflammation in the area. A model
is presented to unify the effects of IFN-γ, SOCS1, SOCS3, and HSV-1 on H3 and chromatin
structure in virus latency or reactivation. HSV-1 latency in the TG is viewed as an active
ongoing process involving maintenance of microglia in an M2 anti-inflammatory state by
IL-10. IL-10 is produced in an autocrine manner by the M2 microglia/macrophages and by
virus-specific CD4+ Foxp3+ Treg cells interacting with virus-specific non-cytolytic CD8+ T
cells.
Keywords: HSV-1, suppressors of cytokine signaling 1 and 3, Tregs, trigeminal ganglion, interferon-gamma

INTRODUCTION
Progression and recrudescence of herpes simplex virus type 1
(HSV-1) infection are intimately involved with IFN-γ. The interactions of HSV-1 and IFN-γ with the host cell cytoskeletal network
and the nuclear epigenetic changes involving histone-3 (H3) are
examined in lytic and latent infection.
IFN-γ has been studied primarily as an immunomodulatory
molecule in macrophages, dendritic cells, and lymphoid cells
(1, 2). The majority of investigations concerning the effects of
IFN-γ on the pathogenesis of HSV-1 involve macrophages and
other immune cells (3, 4). Although the effects of IFN-γ on nonlymphoid cells are not well established, many non-lymphoid cells
in human tissues express receptors for IFN-γ (5). The IFN-γ receptor (IFNGR) is distinctly expressed by endothelial cells and certain
epithelial cells. This review focuses on the effects of IFN-γ on the
cellular events in the pathogenesis of HSV-1 from initial infection
in epithelial cells, especially keratinocytes, to latent infection in
trigeminal neurons.
Since initial infection of humans with HSV-1 is usually unnoticed, extrapolation of observations occurring in murine models
and tissue cultures will be used to portray these events. This review
focuses on:
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1. Cellular receptors for IFN-γ and for HSV-1 and the cytoskeletal
effects of receptor ligation.
2. Epithelial and neuronal cells involved in innate resistance
to HSV-1 and the cytoskeletal effects including intracellular
involvement of pattern recognition receptors (PRRs).
3. Host cell resistance in latency and recurrent infection.
a. Receptor ligation.
b. Modulating cytokines in latency and recurrent infection.

CELLULAR RECEPTORS FOR IFN-γ AND HSV-1
A heterodimer consisting of two chains, IFNR1 and IFNR2, constitutes the IFNGR. Binding of IFN-γ to IFNGR1 induces the
rapid dimerization of each IFNGR1 chain, forming a recognition
site for the extracellular domain of each IFNGR2. The intracellular regions of this IFN-γ-IFNGR complex bring together inactive
JAK1 and JAK2 kinases, which transactivate each other and phosphorylate IFNGR1, forming a paired set of STAT1 docking sites
on the ligated receptor. After binding in close proximity with JAK
kinases, the STAT1 molecules are phosphorylated at tyrosine 701,
which activates the STAT molecules to dissociate from the receptor complex form homodimers and translocate to the nucleus as
specific gene activators (6). Alternately, Johnson et al. (7) obtained
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evidence that suggests a different scenario in which the IFNGR1
chain is complexed to activated STAT1 homodimer and activates
JAKs to bind to a specific sequence in the promoter region of
immediate early (IE) IFN-γ-inducible genes effecting transcription. The activated JAKs are involved in specific epigenetic events
such as phosphorylation of tyrosine 41 on histone H3. In turn,
this results in dissociation of histone inhibitor protein α1 from
histone H3, exposing euchromatin for specific gene activation (7).
The Johnson model is more satisfying intellectually in explaining
the specificity of the transcription factor for the target gene; protein sequences in the IFNGR1 chain would lead the complex to
bind to complementary sequences in a protein associated with the
specific target gene.
Herpes simplex virus type 1 initially infects epithelial cells,
specifically keratinocytes. Dynamin, a microtubule GTPase mediates herpes virus entry into keratinocytes (8). Entry involves both
endocytosis and direct fusion at the plasma membrane, processes
mediated by dynamin and dependent on cholesterol (8, 9). The
various receptors that are known to be involved in HSV-1 entry
are listed in Table 1. Virus entry appears to be cell specific. Certain
cell lines will permit HSV-1 entry through the low pH endocytic
pathway while others exhibit entry through the direct fusion with
plasma membrane of the host cell (10).

Complexity of interferon-γ interactions with HSV-1

Table 1 | HSV-1 glycoproteins involved in virus attachment and entry
(10).
HSV-1 glycoprotein Function

Components

ATTACHMENT PROTEINS
gB and/or gC

Initial

Heparan sulfate proteoglycans (HSPG);

attachment abundantly expressed on the surface
of almost all cell types
HSV-1 ENTRY PROTEINS
gD

Fusion
trigger

HVEM (HveA)
Nectin-1/nectin-2
3-O-sulfated heparan sulfate
proteoglycan (3-OS HS)

gB

Fusogen

Paired immunoglobulin-like type 2
receptor-a (PILRa)
Myelin-associated glycoprotein (MAG)
Non-muscle myosin heavy chain IIA
(NMHC-IIA)

gH-gL

Fusion

ανβ3 integrin

regulator
HSV-1 and host cell cytoskeletal reorganization mediated by HSV-1 entry, microtubule transport to nuclear pore, and replication of virus.

RETROGRADE CELLULAR TRANSPORT OF HSV-1
Following attachment of the virus by fusion, viral capsids are
transported along microtubules to the nuclear pore where the
capsid is uncoated and viral DNA is injected into the nucleus
(11) (Figure 1). Cytoskeletal rearrangements occur within the
infected cell upon binding HSV-1 glycoproteins (12). HSV-1 capsids bind to and traffic along microtubules associated with a
dynein–dynactin complex (13). Dynein, a minus end-directed
microtubule-dependent motor, binds to the incoming capsids and
propels them along microtubules from the cell periphery to the
nucleus (14). The VP26 capsid protein appears to be the main
candidate for viral binding to the dynein motor of microtubules
for retrograde transport to cell nucleus (15). Several tegument
proteins (VP1/2 and UL37) remain associated with the capsid,
which binds to the nuclear pore complex (NPC). After DNA entry
into the nucleus, the capsid with remaining tegument proteins
is retained on the cytoplasmic side of the nuclear membrane
(16). Virus replication occurs in nucleus (16). Sequential gene
expression occurs during replication of HSV-1; the α, IE genes are
involved in organizing the transcriptional elements. The β or early
phase genes carry out the replication of the viral genome and the
βγ/γ late phase genes are involved in expression of structural proteins in high abundance (17). Although the IE α gene regulatory
protein ICP27 enhances viral gene expression and is predominately nuclear, it shuttles to the cytoplasm during HSV infection,
employing an N-terminal nuclear export signal (NES) (18). ICP27
activates expression of β and γ genes by different mechanisms, it
shuts off host protein synthesis; it shuttles between the nucleus and
cytoplasm in regulating late protein synthesis (19). HSV-1 major
capsid proteinVP5 gene (UL19) is expressed with βγ gene kinetics
(20). VP19C is a structural protein of HSV-1 and is essential for
assembly of the capsid. It also contains a NES, which permits it to
shuttle from the cytoplasm to nucleus for virus assembly (21).

Frontiers in Immunology | Immunotherapies and Vaccines

ANTEROGRADE CELLULAR TRANSPORT OF HSV-1
Non-enveloped capsids recruit kinesin-1 (a positive end microtubule motor) and dynein to undergo transport to their site of
envelopment (13). The ability to move bidirectionally appears to
depend on cell type and ensures that the capsids come in contact with the appropriate compartment for further development
(13). Microtubule-mediated anterograde transport of HSV-1 from
the cell nucleus is crucial for the spread and transmission of the
virus (22). The majority of HSV-containing structures attached to
the microtubules contain the trans-Golgi network marker TGN4
(23). This suggests that HSV modifies TGN exocytosis or sorting
machinery, which would accelerate the movement of HSV capsids
to the cell surface. Their conjecture is supported by the observation
that accumulation of HSV particles in cytoplasm is short-lived. In
epithelial cells, 10% of enveloped particles are found in the cytoplasm whereas the remaining 90% of these mature particles are on
the cell surface (23).
In live imaging of infected rat or chicken dorsal root ganglia,
approximately 70% of live viruses undergo axonal transport (24).
The enveloped HSV-1 virions were identified in close association
with neural secretory markers and trafficked to amyloid precursor protein (APP)-positive vesicles during anterograde egress. To
ensure the proper distribution of the cargo (HSV-1 in this case),
both positive and negative motors are attached. APP levels were
found to be well-correlated with the amount of the components
of each motor on the vesicles (25).
SIGNIFICANCE OF EXOSOMES
(MICROVESICLE/L-PARTICLES) IN HSV-1 INFECTION
Electron cryo-tomography was used to visualize HSV-1 interactions with cultured dissociated hippocampus neurons. These
infected cells produced and released both infective virions and
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FIGURE 1 | A simplified version of the complexity of interactions involved in HSV-1 replication is shown (image credit: Graham Colm).

non-infectious particles referred to as light (L) particles or
exosomes (26, 27). L-particles lack capsids and viral DNA (28–
30). Shared assembly and egress pathways were suggested since
virions and L-particles formed in close proximity are often associated with clathrin-like coats (26). In contrast to 2D images of
30–100 nm diameter oxosomes (27, 31), HSV-1 infected cultures
of human foreskin fibroblasts yielded larger 3D images of Lparticles; 280 nm diameter size particles were seen intracellulary
and 177 nm diameter particles were found extracellularly (26). The
complex virus–host interactions at sites of initial HSV-1 infection
permit virus persistence in that these microvesicles may interfere
with host protective immune responses, e.g., preventing antibody
neutralization of infectious virions.
In summary, the cytoskeletal reorganizations involving initial
retrograde transit of HSV-1 to the cell nucleus, where viral replication or latency is initiated, to the anterograde transport and export
of replicated virus depend on a myriad of viral and cytoskeletal
protein interactions. The exosomes exported during lytic infection
add an additional layer of complexity to HSV infections.

HOST CELL CYTOSKELETAL REORGANIZATION MEDIATED BY
IFN-γ
IFN-γ exerts effects on a wide range of cellular programs including:
upregulation of an anti-viral state, antigen processing and presentation, microbicidal activity, immunomodulation, leukocyte
trafficking and apoptosis, and downregulation of cellular proliferation. It orchestrates many of these cellular effects alone or in conjunction with other cytokines or pathogen-associated molecular
patterns (PRRs) or bioactive molecules such as lipopolysaccharide
(LPS) from gram-negative bacteria (1, 32). The effects of IFN-γ
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on the cell’s cytoskeleton are little known. IFN-γ induces a higher
basal level of F-actin and activation of Rac-1 (a GPase), which
affects cytoskeletal rearrangement resulting in decreased phagocytosis by monocyte-derived macrophages (33). During viral entry,
activation of RhoA and Rac-1 results from attachment of Kaposi’s
sarcoma-associated herpes virus (KHV or HHV8) glycoprotein B
(gB) to integrin α3β1; this leads to acetylation and stabilization of
microtubules (12). It is intriguing to speculate that the activation
of Rac-1 by IFN-γ may also enhance cytoskeletal reorganization
and stabilization of microtubules in HSV-1-infected cells. RhoA
and its downstream target Rho kinase are involved in cytoskeletal
reorganization in cells infected with other viruses. The Rho family
GTPase activity within the host cell triggers microtubule stabilization for viral transport during early infection of African swine
fever virus (34).
IFN-γ causes an increase in expression of both class I and
class II MHC molecules on the cell surface. Trafficking of MHC
class II molecules in antigen-presenting cells is dependent on the
cytoskeletal network (35) and is dependent on myosin II, an actinbased motorprotein in B lymphocytes (36). In dendritic cells, the
microtubule-based proteins, dynein and kinesin, determine retention and transport of MHC class II-containing compartments to
the cell surface (37).
Any further effect of IFN-γ on the cell cytoskeleton involves
indirect association with the effects of this molecule on GTPases
involved in cell migration (38). IFN-γ inhibits monocyte migration by suppressing actin remodeling of the cytoskeleton and
polarization in response to chemokine CCL2, a STA1-dependent
process modulating activity of Pyk2, JNK, and the GTPases Rac
and Cdc42 (38). Rho kinase (ROCK) is a downstream effector of
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Rho GTPase and regulates many crucial cellular processes through
its control of actin and microtubules (39). In an adenocarcinoma
colonic (T84) cell line, IFN-γ treatment activated Rho GTPase
that upregulated expression of Rho-associated kinase (ROCK),
which then mediated internalization of tight junction proteins
from the apical plasma membrane into actin-coated vacuoles;
this process was dependent on the ATPase activity of a myosin
II motor (40).
Either HSV-1 infection or IFN-γ treatment upregulated expression of suppressor of cytokine signaling 1 (SOCS1) in murine
keratinocyte cell lines (41). SOCS1 expression was magnified
in IFN-γ-treated HSV-1 infected keratinocytes, reflecting a profound inhibition of the IFN-mediated anti-viral effect in both
the cytoplasm and nucleus of infected keratinocytes. Yokota
et al. (42) noted that SOCS3 induction varied among cell
lines. They observed that HSV-1 rapidly induced expression of
SOCS3 in a human amniotic cell line (FLcells) resulting in efficient viral replication. In human monocytic cell lines (U937
or THP1), HSV-1 did not induce SOCS3 expression; a persistent infection producing low virus yields resulted in those
cells (42).
IFN-γ promotes expression of SOCS1 at the transcriptional
level (43). As shown in Figure 2, SOCS1 localizes to the microtubule organizing center (MTOC) (44) as does SOCS3 (45). Both
SOCS1 and SOCS3 enhance FAK- and RhoA-activation leading to
increased cell adhesion and reduced migration (46).
In summary, IFN-γ exerts anti-viral effects, induces expression
and trafficking of MHC class II molecules in antigen-presenting
cells, effects actin cytoskeletal reorganization involved in phagocytosis and microtubule destabilized bundle formation. In contrast,
IFN-γ contributes to microtubule stabilization by upregulating
expression of SOCS1 and SOCS3.

FIGURE 2 | Hypothetical effect of IFN-γ on microtubules of an
HSV-1-infected trigeminal neuron (image credit: Trista D. Smith). Herpes
simplex virus type 1 invades nerve endings, which is transmitted by
microtubule motor proteins via retrograde transport and its DNA is deposited
into the nucleus of the cell (47). IFN-γ induces expression of both SOCS1 and
SOCS3 (48), but also interferes with the correct assembly of microtubules
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HSV-1 LYTIC VERSUS LATENT INFECTION
Lytic HSV-1 infection occurs in epithelial cells. As indicated in
Table 1, the virus attaches to cell membrane receptors such as
heparan sulfate (52), facilitated by viral glycoproteins B (gB) and
C (gC) (53). Glycoprotein D (gD) facilitates virus adsorption to
the host cell and glycoproteins H and L (gH and gL) are responsible
for membrane penetration of the virus into the host cell [reviewed
in Ref. (53)]. Furthermore, Dingwell et al. (54) demonstrated that
glycoproteins E and I (gE and gI) are responsible for HSV-1 spread
from one neuron to another neuron. In lytic infection, virus IE
genes (α genes) are expressed first, followed by expression of early
β genes, DNA replication, and expression of late γ genes. The
maximum rate of synthesis by α genes occurs 3–4 h post infection. The β genes are responsible for the highest rate of synthesis
5–7 h post infection. The synthesis of γ genes increases until 12 h
post infection. Use of the protein synthesis inhibitor, cycloheximide, confirmed that IE polypeptides expression occurs without
prior viral protein synthesis (55). The IE genes consist of ICP0,
ICP4, ICP22, ICP27, ICP47, and Us1.5 (56). Wysocka and Herr
(57) revealed that IE genes have VP16-response elements (VRE).
In latency, a single transcript is generated, which encodes a precursor for four distinct HSV miRNAs, which act to suppress virus
replication (58).
In the establishment phase of latency, the virus enters the neuronal cell in which the viral genome remains transcriptionally
quiescent. The integrity of the neuron is not compromised, as
the cytopathic effect of the productive infection does not occur
(59). During establishment of latent infection, gene expression
is limited to a gene located within the long repeat elements of
the viral genome. Transcription of this gene results in generation
of the latency-associated transcripts (LATs) (60). The LAT transcripts (RNAs) have open reading frames; however, the detection

causing them to undergo bundling (49). Both SOCS1 and SOCS3 promote the
stability of the microtubule network (45, 50). In addition, SOCS3 maintains
the integrity of the MTOC by anchoring it to the centrosome (45). Cytokines
produced by neighboring cells, e.g., IL-6 and IL-10 by macrophages/microglia,
stimulate activation of STAT3; STAT3 stimulates a much stronger induction of
SOCS3 in response to IL-10 when compared to IL-6 (51).
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of a protein encoded by the LATs has not been observed (58, 61).
LAT expression is not an absolute indication of latency establishment (62), as LAT-defective HSV-1 can establish latent infection
in mice (28). In contrast, Thompson and Sawtell (63) found that
the LAT gene plays a role in establishment of latency, but LAT has
no direct role in the HSV-1 reactivation. They found that approximately 30% of the trigeminal ganglion (TG) neurons in mice
infected with LAT+ HSV-1 harbored latent virus, but only 10%
of the neurons in mice infected with LAT-null viruses were positive for HSV-1 DNA. LAT expression has no demonstrable effect
on neuronal cell survival at 3 and 31 days after infection with
defective HSV-1 (thymidine kinase-deleted) mutants (64). LAT
expression was not necessary for cell survival during TK-deleted
virus infection.
Establishment of latency may result from the inability of IE
genes to induce lytic infection. Marshall et al. (65) showed that
HSV-1 established latency in mice in the presence of impaired IE
gene expression and the latency was not affected by restoration of
VP16, ICP0, or ICP4 coding sequences. These observations suggest
that the latency is increased when IE gene expression is inadequate
to initiate the lytic infection. The presence of HSV-1 DNA in the
nucleus of infected neurons is an important factor for HSV-1 to
establish latency (56). During latency, the role of VP16 to initiate
lytic gene expression may be inhibited by a defect in the VP16
transport from nerve endings to the neuronal cell body, or due
to the presence of this protein in reduced amounts in the neurons
(66). Two competitive inhibitors for transcription of VP16, namely
the octamer-binding protein (Oct-2) (67) and N-Oct3 (68) compete with VP16 for binding to an α gene promoter. VP16 fails to
form a complex with HCF-1 in the Golgi apparatus of sensory
neurons. The HCF-1 protein moves to the nucleus upon reactivation of HSV-1 in vitro (69). In humans, HSV-1 reactivation can be
spontaneous or results from exposure to ultraviolet (UV) irradiation, emotional stress, fever, or immune suppression. Reactivation
causes shedding of the virus transported through neuronal axons
to the epithelial cells where it can replicate and start a lytic cycle.
Hyperthermia efficiently induced HSV-1 reactivation from latency
in a few neurons of the TG in infected mice (70). In latency, a single
transcript is generated, which encodes a precursor for four distinct
HSV miRNAs, which act to suppress virus replication (71).

IMMUNE RESPONSE TO HSV-1
Initial host responses to viral infection include production of
interferons-α/β by the first cells infected, IFN-γ by human natural killer (NK) cells recognizing the gB and gC of virus-infected
targets (72), and proinflammatory cytokines and chemokines by
monocytic cells (73). Viruses are recognized by the innate immune
system through PRRs such as the Toll-like receptors (TLRs). HSV
virions are recognized by the cell membrane TLR2 and intracellular HSV genomic DNA is recognized by the cytoplasmic
TLR9. Dendritic cells recognize HSV using both TLR2 and TLR9
(74). Virus-induced IFN-α and IFN-γ are products of human
peripheral mononuclear leukocytes (PML) exposed to UV and
light-inactivated HSV (75). In the innate response to HSV-2,
TLR2 and TLR9 restrict viral load in the brain by synergizing
to induce an early cytokine (type I IFN, IL-6, IL-12, RANTES)
and cellular responses (76, 77). In mice lacking both TLR2 and
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TLR9, HSV induces uncontrolled virus replication and lethal
encephalitis (77).

THE ROLE OF EXOSOMES (MICROVESICLES OR L-PARTICLES)
IN HSV-1 IMMUNITY
Both B cell and T cell immune responses develop during primary
viral infection. However, early viral evasion strategies interfere
with complete elimination of virus and permit persistence of
HSV-1. During HSV-1 infection, microvesicles/exosomes containing viral tegument proteins and glycoproteins, some of which are
early transcription factors, are released. Because these virus-like
vesicles lack both the viral capsid and DNA, they cannot produce a replication-infective cycle, but can interfere with immune
elimination of virus (29, 30, 78). Also, the viral envelope gB is
involved in inhibiting the MHCII molecule antigen-processing
pathway by coupling with HLA-DR and shunting the complex
through microvesicles/exosomes instead of the cell surface (31).
This capture of the gB-HLA-DR complex puts complexes into
the cellular microenvironment to induce tolerance in bystander T
cells (27, 31).
IMMUNE EFFECTOR CELLS AND LATENCY
An understanding of the mechanisms that control the HSV-1
latency is elusive. Reactivation from latency is associated with
pathological disease due to shedding of the reactivated virus from
the sensory ganglia (79). CD8+ T cells can inactivate HSV-1 without inducing neuronal apoptosis. It was shown that CD8+ T
cell lytic granules, granzyme B, can destroy the HSV-1 IE protein, ICP4, which acts as transactivator of β genes required for
viral DNA replication. HSV-1 latency is accompanied by chronic
inflammation without neuronal damage (80). Trigeminal ganglia
latently infected with HSV-1 are infiltrated with CD3+ and CD8+
T cells, CD68-positive macrophages, IFN-γ, tumor necrosis factorα (TNF-α), IP-10, and RANTES. These observations suggest that
the presence of the immune cells and elevated levels of cytokines
within the latently infected trigeminal ganglia are responsive to the
clinical use of immunosuppression drugs and subsequent reactivation of virus in the cranial nerves. Immune cell infiltration
in latently infected trigeminal ganglia may occur in response to
spontaneous reactivation of some neurons leading to expression
of HSV-1 lytic cycle transcripts (81). Because of the absence of
detectable virus in latently infected TG, this process was referred
to as spontaneous molecular reactivation.
CD8+ T cells and macrophages/microglia and their cytokine,
TNF-α, exert a role in maintaining HSV-1 latency in the trigeminal ganglia. However, NK cells and γδ T cells and their production
of IFN-γ play a role in preventing viral replication during the
lytic infection (82). HSV-specific CD8+ T cells migrate to and
are retained in the ophthalmic branch of the TG after intraocular
infection (83). In the absence of replicating virus, HSV-1-specific
CD8+ T cells remain active, secreting IFN-γ in the latent TG.
The activated virus-specific memory CD8+ T cells, expressed the
CD94-NK cell receptor subfamily G2a inhibitory molecule. These
cells were not cytotoxic for the Qa-1b -expressing neuronal targets,
of which there were many in the HSV-1 latent TG. When the Qa1b /CD94-NKG2a interaction was blocked in ex vivo experiments,
neuronal lysis occurred. Since TGF-β1 can induce expression of
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the inhibitory CD94-NKG2a molecules, the source of bioactive
TGF-β1in the latent TG was attributed to CD4+ Foxp3 Treg cells
also present in the latent TG (83). These observations indicate the
presence of a regulatory system that protects irreplaceable neurons from immune destruction (83). Qa1 expression, whether on
neurons or lymphoid cells present in the TG, is protected; binding of CD94/NKG2a to Qa1 on activated CD4+ T cells provides
protection from NK cell-mediated lysis (84).

IFN-γ AND HSV-1 INDUCE EXPRESSION OF SOCS1
SOCS1 expression in response to IFN-γ by sensory neuronal cells,
but not by microglia, is responsible for the lack of expression
of class I MHC molecules by sensory neurons (85). HSV-1 can
evade the immune response by SOCS1 expression (41). HSV-1 is
resistant to anti-viral effect of IFN-γ in keratinocytes, the major
cell replicating virus in recurrent lytic infection. HSV-1-infected
keratinocytes exhibit high levels of SOCS1 mRNA and protein
expression by preventing STAT1α activation in response to IFN-γ
signaling. In this same study, viral ICP0 was involved in activating host cell SOCS1 gene; i.e., both IFN-γ and HSV-1 induced
expression of SOCS1 in keratinocytes (41).
The conundrum involving the association and interactions of
histones, HSV-1, IFN-γ, and SOCS1/3 in herpesvirus infection
and latency is intriguing. Protein acetylation is important in herpesvirus infection as well as in activation of IFN-γ-stimulated
genes. Histone acetylation determines how tightly the DNA is
wound around the histones. In histones H3 and H4, chromatin
is relaxed and accessible to the transcriptional proteins and subsequent increase in gene transcription. In areas of hypoacetylation,
chromatin is condensed and genes are silenced (86). Histone
deacetylases (HDACs) are transcriptional and epigenetic regulators controlling HSV-1 infection (87). Trichostatin A (TSA), an
HDAC inhibitor, suppresses JAK2/STAT3 or JAK3/STAT3 signaling
by inducing the promoter-associated histone acetylation of SOCS1
and SOCS3 (88). TSA treatment causes a relaxation of the chromatin structure, a process essential for initiation of transcription.

FIGURE 3 | Schematic representation of events contributing to HSV-1
latency and lytic cycle. IFN-γ secreted by CD94: NKG2a NK cells and
virus-specific, but non-lytic, CD8+T cells maintain virus in the latent state;
HDAC maintains chromatin in an inactive state and is necessary for
transcription of IFN-γ-activated genes and for its anti-viral effect. When HDAC
is inhibited by stressor (e.g., UV light), SOCS1 and SOCS3 are acetylated,
chromatin is relaxed and accessible for virus transcription, and virus is shed.
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Induction of SOCS1 and SOCS3 expression by TSA is associated
with an increase in acetylation of H3 and H4 histone proteins in
colorectal cancer cells (88). TSA treatment of HSV-1-quiescently
infected neurons induces a productive lytic infection (89). HDAC
is essential for the transcriptional activation of IFN-γ-stimulated
genes and for host anti-viral immune responses; TSA treatment of
cell cultures (HepG2, Huh7, and HeLa cells) promoted the proteasomal degradation of IFN regulatory factor 1 (IRF-1) (90). These
observations contribute to a deeper understanding of the fact that
IFN-γ is essential in the TG to maintain virus latency. When IFN-γ
is neutralized by specific antibody, virus replication occurs in the
brain stem of latently infected mice (3).
When SOCS1 level is elevated over that of SOCS3 in
macrophages/microglia, an inflammatory M1 phenotype exists
secreting inflammatory cytokines (Bigley et al., unpublished
observations) and when SOCS3 predominates in these cells,
an anti-inflammatory phenotype exists (91). SOCS3 is involved
in attenuating the cytokine-induced inflammatory response in
macrophages and microglia by production of endogenous IL-10
and STAT3 activation (92). These observations are illustrated in
Figure 3.

CONCLUSION
The actin–microtubule cytoskeletal reorganizations that occur in
response to HSV-1 infection permit retrograde and anterograde
transit of HSV-1 in lytic infection as well as the epigenetic changes
that occur in HSV latent and lytic infections. IFN-γ suppression of actin remodeling of the cytoskeleton may influence its
anti-viral effect. Cytoskeletal reorganizations involved in retrograde transport of HSV-1 to the neuronal cell nucleus, where
viral replication or latency is initiated, to the anterograde transport and export of replicated virus depend on a variety of viral
and cytoskeletal protein interactions. A unifying model is proposed to explain latency and emergence from latency at histone
H3 sites in nuclei of sympathetic neurons as an active ongoing process. Maintenance of latency involves intimate interactions

SOCS1 prevents expression of MHC class 1 molecules on neuronal cells and
SOCS3 is involved in attenuating cytokine-induced inflammation in the area.
Stimulated M2 microglia produce SOCS3 as well as the immunosuppressive
molecule – IL-10, which is also produced by virus-specific CD4+ Foxp3+ Treg
cells. IL-10 exerts a local protective anti-inflammatory effect by maintaining the
microglia/macrophages in the M2 anti-inflammatory state in which SOCS3
expression predominates.
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among immune cells, virus-specific non-lytic CD8+ cytotoxic T
cells and CD4+ CD25+ Foxp3+ Treg cells, and M2 microglia. HSV1 latency occurs when HDAC maintains chromatin in an inactive
state permitting IFN-γ produced by NK cells and non-cytolytic
CD8+ T cells to exert its anti-viral effect. The anti-inflammatory
state of the M2 microglia/macrophages is maintained by IL-10 produced by the SOCS3-producing M2 microglia/macrophages and
by virus-specific CD4+ Foxp3+ Treg cells. When HDAC is inhibited, SOCS1 and SOCS3 are acetylated and chromatin is relaxed,
permitting virus transcription and replication and anterograde
transport and shedding of HSV-1 in a lytic cycle of infection.
Modulation of SOCS1–SOCS3 expression is a potential strategy
for the treatment of not only viral infections but also inflammatory
diseases.
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